Keros Therapeutics
KROS
KROS
138 hedge funds and large institutions have $480M invested in Keros Therapeutics in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 34 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 156 → 138 (-18)
19% less call options, than puts
Call options by funds: $13.3M | Put options by funds: $16.4M
40% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 43
Holders
138
Holding in Top 10
4
Calls
$13.3M
Puts
$16.4M
Top Buyers
| 1 | +$52.7M | |
| 2 | +$36.3M | |
| 3 | +$18.9M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.08M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.38M |
Top Sellers
| 1 | -$52.3M | |
| 2 | -$34.5M | |
| 3 | -$11.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.7M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$4.74M |